Dose-related sevoflurane metabolism to inorganic fluoride in rabbits
- PMID: 1864761
Dose-related sevoflurane metabolism to inorganic fluoride in rabbits
Abstract
Serum concentrations and urinary excretion of inorganic fluoride (fluoride ion), a metabolite of sevoflurane, were measured by an ion-chromatographic analyzer after inhalation of three different concentrations of sevoflurane in adult, male Japanese white rabbits weighing 2.6-3.6 kg. Sevoflurane was administered at concentrations of 0% (control), 1%, 2% and 3% (Groups I, II, III and IV, respectively) through a sevoflurane vaporizer for 2 hr under controlled ventilation. Blood and urine samples were collected during and after termination of sevoflurane inhalation at scheduled time intervals for 24 hr. The total volume of urine, the urinary pH and the osmolality of serum and urine were not significantly different among any of the groups. Osmolality of the serum and urine was within normal range in all groups of animals. The mean serum peak values of fluoride ion were 0.7 +/- 0.5, 22.8 +/- 8.7, 31.8 +/- 11.0 and 41.5 +/- 13.2 microM (mean +/- SD) in groups I, II, III and IV, respectively. Peak values were recorded within 15 min after the termination of inhalation. The cumulative amounts of fluoride ion excreted in urine in 24 hr were calculated to be 5.0 +/- 1.6, 26.1 +/- 6.7, 41.4 +/- 11.3 and 64.3 +/- 18.0 mumol (mean +/- SD) in groups I, II, III and IV, respectively. Regression analysis revealed significant correlations between the formation and excretion of fluoride ion, and the dose of sevoflurane (r = 0.85, p less than 0.05 and r = 0.89, p less than 0.05, respectively). The authors conclude that the formation and excretion of fluoride ion after sevoflurane anesthesia is dependent on the dose of the drug.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Biotransformation of sevoflurane in dogs and rats.Anesth Analg. 1981 Apr;60(4):186-91. Anesth Analg. 1981. PMID: 6782910
-
Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations.Transplant Proc. 2007 Jun;39(5):1544-8. doi: 10.1016/j.transproceed.2007.01.081. Transplant Proc. 2007. PMID: 17580185
-
Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation.Anesthesiology. 1995 Jun;82(6):1379-88. doi: 10.1097/00000542-199506000-00009. Anesthesiology. 1995. PMID: 7793652 Clinical Trial.
-
Metabolism and toxicity of the new anesthetic agents.Acta Anaesthesiol Belg. 1996;47(1):7-14. Acta Anaesthesiol Belg. 1996. PMID: 8651050 Review.
-
Biotransformation of sevoflurane.Anesth Analg. 1995 Dec;81(6 Suppl):S27-38. doi: 10.1097/00000539-199512001-00005. Anesth Analg. 1995. PMID: 7486145 Review.
Cited by
-
Sevoflurane and its metabolic byproduct compound A induce nephrotoxicity: a systematic review and meta-analysis of animal studies.Med Gas Res. 2025 Jun 1;15(2):254-265. doi: 10.4103/mgr.MEDGASRES-D-24-00080. Epub 2025 Jan 18. Med Gas Res. 2025. PMID: 39829162 Free PMC article.